Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 5.05% is 99% below its 2-year average of 356.76%, near the low end of its 2-year range (-24.29%–3551.10%).
99.29% below its 12-month average of 711.68%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 3551.10%.
EBITDA MARGIN
5.05%
EBITDA MARGIN AVG TTM
711.68%
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-99.29%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Park Dental Partners, Inc. Common Stock
Market Cap
$93.48M
EBITDA Margin
5.05%
TTM Avg
711.68%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$90.73M
EBITDA Margin
-19.79%
TTM Avg
-29.84%
3Y Avg
-150.95%
5Y Avg
-150.95%
Market Cap
$90.16M
EBITDA Margin
-35.83%
TTM Avg
-39.56%
3Y Avg
-111.97%
5Y Avg
-250.85%
Market Cap
$89.46M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$89.36M
EBITDA Margin
-3260.14%
TTM Avg
-6375.74%
3Y Avg
-6375.74%
5Y Avg
-6375.74%
Market Cap
$89.34M
EBITDA Margin
15.84%
TTM Avg
9.89%
3Y Avg
0.86%
5Y Avg
4.00%
Market Cap
$86.95M
EBITDA Margin
31.45%
TTM Avg
-14.67%
3Y Avg
-906.21%
5Y Avg
-1050.55%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Park Dental Partners, Inc. Common Stock (PARK) | $93.48M | 5.05% | 711.68% | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $91.30M | N/A | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $90.73M | -19.79% | -29.84% | -150.95% | -150.95% |
| electroCore, Inc. (ECOR)vs › | $90.16M | -35.83% | -39.56% | -111.97% | -250.85% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.60M | N/A | N/A | N/A | N/A |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $89.46M | N/A | N/A | N/A | N/A |
| Rallybio Corporation (RLYB)vs › | $89.36M | -3260.14% | -6375.74% | -6375.74% | -6375.74% |
| ImmuCell Corporation (ICCC)vs › | $89.34M | 15.84% | 9.89% | 0.86% | 4.00% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $86.95M | 31.45% | -14.67% | -906.21% | -1050.55% |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 23.63% | 23.21% | 8.97% | 9.09% |
Gross Margin
10.9%
EBITDA Margin
5.0%
Operating Margin
-2.8%
Net Margin
-1.4%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 3551.10% |
| 2026-03-31 | 0.80% |
| 2025-12-31 | -9.57% |
| 2025-09-30 | 6.82% |
| 2025-06-30 | 9.27% |
| 2025-03-31 | 9.27% |
| 2024-12-31 | -24.29% |
| 2024-09-30 | 6.39% |
| 2024-06-30 | 8.90% |
| 2024-03-31 | 8.90% |
